Real-time enrollment status for this transthyretin amyloidosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05489523 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 25 participants |
| Active Locations | 4 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | September 5, 2025 (Sep 5, 2025) |
As of March 2, 2026: Clinical trial NCT05489523 is currently recruiting participants. This clinical trial study for transthyretin amyloidosis is actively seeking new participants at 4 locations across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05489523 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05489523 was last updated Sep 5, 2025 (September 5, 2025). HelloStudys verifies this status automatically.